Torsten Haneke und Preclinical - Info zur Person

(1 - 15 von 16

)

Affimed (AFMD) Presents Preclinical Data of Novel Innate Cell ...StreetInsider

www.streetinsider.com

Authors: Jana-Julia Siegler, Nanni Schmitt, Jens Pahl, Torsten Haneke, Izabela Kozlowska, Séverine Sarlang, Alexandra Beck, Stefan Knackmuss, Paulien ... Authors: Jana-Julia Siegler, Nanni Schmitt, Jens Pahl, Torsten Haneke, Izabela Kozlowska, Séverine Sarlang, Alexandra Beck, Stefan Knackmuss, Paulien ...

Affimed Presents Preclinical Data of Novel Innate CellGlobeNewswire

www.globenewswire.com

— Authors: Jana-Julia Siegler, Nanni Schmitt, Jens Pahl, Torsten Haneke, Izabela Kozlowska, Séverine Sarlang, Alexandra Beck, Stefan Knackmuss — Authors: Jana-Julia Siegler, Nanni Schmitt, Jens Pahl, Torsten Haneke, Izabela Kozlowska, Séverine Sarlang, Alexandra Beck, Stefan Knackmuss ...

Affimed Presents Preclinical Data of Novel Innate Cell Engager ...FirstWord Pharma

firstwordpharma.com

Authors: Jana-Julia Siegler, Nanni Schmitt, Jens Pahl, Torsten Haneke, Izabela Kozlowska, Séverine Sarlang, Alexandra Beck, Stefan Knackmuss, ... › story

Affimed (AFMD) to Present Preclinical Data Demonstrating Cytotoxic...

www.streetinsider.com

Authors: Jana-Julia Siegler, Nanni Schmitt, Jens Pahl, Torsten Haneke, Izabela Kozlowska, Séverine Sarlang, Alexandra Beck, Stefan Knackmuss, ... › Aff...

Affimed to Present Preclinical Data Demonstrating ...Yahoo Finance

finance.yahoo.com

Affimed Presents Preclinical Data of Novel Innate Cell ...Affimed

www.affimed.com

— ... Torsten Haneke, Izabela Kozlowska, Séverine Sarlang, Alexandra Beck, Stefan Knackmuss, Paulien Ravenstijn, Uwe Reusch, José Medina-Echeverz — ... Torsten Haneke, Izabela Kozlowska, Séverine Sarlang, Alexandra Beck, Stefan Knackmuss, Paulien Ravenstijn, Uwe Reusch, José Medina-Echeverz ...

Preclinical characterization of the bispecific EGFR/CD16A ...Westsächsische Hochschule Zwickau

www.katalog.fh-zwickau.de

... Torsten Haneke, Susanne Wingert, Michael Damrat, Michael Tesar, Martin Treder. Preclinical characterization of the bispecific EGFR/CD16A innate immune cell Torsten Haneke, Susanne Wingert, Michael Damrat, Michael Tesar, Martin Treder. Preclinical characterization of the bispecific EGFR/CD16A innate immune cell ...

Preclinical evaluation of AFM24, a novel CD16A-specific ...Europe PMC

europepmc.org

von S Wingert · · Zitiert von: 39 — ... Torsten Haneke. aResearch & Development, Affimed GmbH, Heidelberg, Germany. Find articles by Torsten Haneke. Joachim Koch. aResearch & Development, Affimed GmbH ... von S Wingert · · Zitiert von: 39 — ... Torsten Haneke. aResearch & Development, Affimed GmbH, Heidelberg, Germany. Find articles by Torsten Haneke. Joachim Koch. aResearch & Development, Affimed GmbH ...

Preclinical evaluation of AFM24, a novel CD16A-specific ...National Institutes of Health (NIH) (.gov)

pubmed.ncbi.nlm.nih.gov

von S Wingert · · Zitiert von: 39 — Thomas Mueller , Ivica Fucek , Kristina Ellwanger , Michael Tesar , Torsten Haneke , Joachim Koch , Martin Treder , Wolfgang Fischer , Erich ... von S Wingert · · Zitiert von: 39 — Thomas Mueller , Ivica Fucek , Kristina Ellwanger , Michael Tesar , Torsten Haneke , Joachim Koch , Martin Treder , Wolfgang Fischer , Erich ...

Preclinical Characterization of AFM26, a Novel B Cell ...ashpublications.org

ashpublications.org

— Torsten Haneke, PhD,. Torsten Haneke, PhD *. 1Affimed GmbH, Heidelberg, Germany. Search for other works by this author on: This Site · PubMed — Torsten Haneke, PhD,. Torsten Haneke, PhD *. 1Affimed GmbH, Heidelberg, Germany. Search for other works by this author on: This Site · PubMed.